LITTLE ROCK, Arkansas. -Vivione Biosciences Inc. (the “Corporation”) (TSX:VBI), through its wholly owned subsidiary, Vivione Biosciences, LLC, announced today that it has signed a strategic alliance agreement with Institute for Environmental Health, Inc (“IEH”), a Washington-based lab service provider, to handle all laboratory testing for the Corporation’s new oil and gas service offerings. IEH is […]

CAMBRIDGE, Mass. — NextCODE Health, which puts whole-genome analysis in the hands of clinicians and researchers worldwide, today announced the start of a partnership with the Academic Centre on Rare Diseases (ACoRD) at University College Dublin. ACoRD will use NextCODE solutions to take full advantage of the latest sequencing technologies to improve the diagnosis and […]

We are delighted to announce that PTI has joined the HORIBA family of companies and will be part of HORIBA’s Scientific segment. PTI is a leading supplier of research spectrofluorometers, serving the university and research labs, industrial and biomedical markets. PTI is the world leader in microscopy-based fluorometers, especially for intracellular ion imaging. PTI also […]

Cambridge, UK — Horizon Discovery™ Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered into a non-exclusive license agreement with Stanford University to access intellectual property related to the use of a proprietary serotype of AAV (Adeno-Associated Virus) for […]

CORALVILLE, IA – – Integrated DNA Technologies (IDT) has acquired the SURVEYOR® enzyme business of Transgenomic, Inc. Already the world leader in custom nucleic acid synthesis, IDT is expanding its molecular biology product offerings by adding the SURVEYOR enzyme and kits. As part of the agreement with Transgenomic, IDT will acquire the SURVEYOR product line […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has entered into an agreement to sell to Integrated DNA Technologies, Inc. (IDT) the rights to Transgenomic’s SURVEYOR Nuclease technology and assets […]

Minneapolis — Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that it has acquired Novus Biologicals for $60 million in cash. The transaction was financed with cash on hand. Novus Biologicals is a Littleton, Colorado-based supplier of a large portfolio of both outsourced and in-house developed antibodies and other reagents for life science research. Their […]

SP Industries, Inc. (SP), a leading designer and manufacturer of state-of-the-art laboratory equipment, biological drug manufacturing solutions, and specialty glassware, has announced that it has acquired privately held Bel-Art Products (Bel-Art). Headquartered in Wayne (NJ, USA), Bel-Art is a global provider of innovative laboratory solutions serving the scientific, industrial, and healthcare end markets. Through this […]

Eurofins Genomics, international market leader in genomic services, and AmpTec, internationally recognized provider of RNA technology products, have agreed on non-exclusively co-marketing AmpTec’s IVT-RNAs globally. The co-marketing agreement for IVT ssRNAs, dsRNAs and mRNAs includes RNAs up to several thousand bases and a wide range of modifications. All nucleic acid products are offered at research […]